APA (7th ed.) Citation

N, J., K, H., S, T., W, F., O, H., MCJ, M., . . . MR, G. (2019). Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma. Science translational medicine, 11(497), . https://doi.org/10.1126/scitranslmed.aav5599

Chicago Style (17th ed.) Citation

N, Jain, et al. "Targetable Genetic Alterations of TCF4 (E2-2) Drive Immunoglobulin Expression in Diffuse Large B Cell Lymphoma." Science Translational Medicine 11, no. 497 (2019). https://doi.org/10.1126/scitranslmed.aav5599.

MLA (9th ed.) Citation

N, Jain, et al. "Targetable Genetic Alterations of TCF4 (E2-2) Drive Immunoglobulin Expression in Diffuse Large B Cell Lymphoma." Science Translational Medicine, vol. 11, no. 497, 2019, https://doi.org/10.1126/scitranslmed.aav5599.

Warning: These citations may not always be 100% accurate.